EQS-News

MENARINI GROUP: THOMAS CUENI APPOINTED NEW MEMBER OF THE BOARD 07.05.2026, 15:55 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: Menarini Industrie Farmaceutiche Riunite / Key word(s): Personnel
MENARINI GROUP: THOMAS CUENI APPOINTED NEW MEMBER OF THE BOARD

07.05.2026 / 15:55 CET/CEST
The issuer is solely responsible for the content of this announcement.


FLORENCE, Italy, May 7, 2026 /PRNewswire/ -- The Menarini Group's Board of Directors has appointed the experienced executive Thomas Cueni as a new Director, further strengthening the Group's governance. Cueni joins Chairman Eric Cornut, CEO Elcin Barker Ergun, shareholders Lucia and Alberto Giovanni Aleotti, and Carlo Colombini on the Board of the pharmaceutical multinational.

Thomas Cueni, Menarini Group Board Member (PRNewsfoto/Menarini Industrie Farmaceutiche Riunite)

With nearly forty years of international experience in the pharmaceutical sector, Cueni has held leading roles, including Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and member of the Board of Directors of the European Federation of Pharmaceutical Industries and Associations (EFPIA). In these roles, he has played a leading role in forging cross-sector initiatives to address access to treatment for chronic diseases and shape policies tackling global health challenges such as the COVID-19 pandemic. In the field of anti-microbial resistance, he established the nearly USD 1 billion AMR Action Fund to support the development of new antibiotics. He was also Founding President of the AMR Industry Alliance, one of the largest private sector coalitions to provide sustainable solutions to curb anti-microbial resistance.

"I am proud to bring all my experience and commitment to the Menarini Group – declared Cueni – joining a growing and dynamic company that is combining scientific excellence, innovation, and commitment to global health represents a unique opportunity for me to contribute to what I care for: improving the lives of patients wherever they live".

"We are very pleased to welcome Thomas Cueni to Menarini – commented shareholders and Board members Lucia and Alberto Giovanni Aleotti - his extensive experience in global health policy leadership aligns closely with our mission to combine innovation and responsibility in ways that help improve patient care. His appointment represents not only a strengthening of our leadership but also a fundamental contribution to our ability to face the challenges of a constantly evolving pharmaceutical industry, in an increasingly complex global geopolitical context. We wish to express our sincere and personal gratitude to Jürg Witmer for his passion, commitment and the value he has brought to the Board over the past 13 years, as he steps down".

The Menarini Group, with headquarters in Florence, is present in 140 countries worldwide to date, with €4.88 billion in consolidated turnover and more than 17,000 employees. Menarini's products are present in the most important treatment areas, including those of cardiometabolic, oncology, gastroenterology, pneumology, and anti-inflammatory/analgesic products. Through its commitment in R&D and high quality manufacturing activities, Menarini continuously contributes to patients' health worldwide, maintaining the highest quality standards. www.menarini.com

Photo - https://mma.prnewswire.com/media/2975013/Thomas_Cueni_Menarini_Group.jpg
Logo - https://mma.prnewswire.com/media/2296569/Menarini_Industrie_Farmaceutiche_Riunite_Logo.jpg

Menarini Industrie Farmaceutiche Riunite Logo (PRNewsfoto/Menarini Industrie Farmaceutiche Riunite)

 

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/menarini-group-thomas-cueni-appointed-new-member-of-the-board-302765731.html

rt.gif?NewsItemId=EN54053&Transmission_Id=202605070951PR_NEWS_EURO_ND__EN54053&DateId=20260507


07.05.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2323422  07.05.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer